Ember Therapeutics, Inc. (EMBT)
0.0000
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.00 |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 0.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 100.00% |
Profile
| Ember Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the provision of treatment for metabolic disorders and obesity diseases. Its focuses on utilizing Bone Morphogenetic Protein-7 and related family of Bone Morphogenetic Proteins, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis. The company was founded on January 20, 1987 and is headquartered in New York, NY. |
| URL | http://www.embertx.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | Jul. 26, 2007 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Ember Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the provision of treatment for metabolic disorders and obesity diseases. Its focuses on utilizing Bone Morphogenetic Protein-7 and related family of Bone Morphogenetic Proteins, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis. The company was founded on January 20, 1987 and is headquartered in New York, NY. |
| URL | http://www.embertx.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | Jul. 26, 2007 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |